Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Leonard S. Rosenberg is active.

Publication


Featured researches published by Leonard S. Rosenberg.


Drug Development and Industrial Pharmacy | 1989

Application of a Second-Order Derivtive Spectroscopic Technique: Determination of the Ionization Constants of Phenytoin and Phenobarbital

Leonard S. Rosenberg; Jenny L. Jackson

AbstractAbsorption spectroscopy can be used to determine the pK of a compound when a change in the spectral pattern can be related to a change in the protonation state of an ionizable group. The calculation of a pK becomes difficult (standard error increases) when these spectral changes are indistinct or are minimally resolved. In these cases, the ability of higher-order derivative spectroscopy to enhance the short-range fine structure of a spectra usually offers adequate spectral resolution for quantitative pK determinations.


Pharmaceutical Research | 1988

An accurate prediction of the ph change due to degradation correction for a produced secondary buffering system

Leonard S. Rosenberg; Cheryl K. Hostetler; Dietmar M. Wagenknecht; Diane A. Aunet

Esmolol hydrochloride degrades in aqueous solutions by the hydrolysis of a labile aliphatic carboxy-ester group. The products are methanol and ASL-8123. The resulting aliphatic carboxylic acid moiety (ASL-8123) has a pK of 4.80, which is within 1 pH unit of the pH of the formulation. ASL-8123 therefore acts as a “secondary buffer” and minimizes the change in pH due to degradation. Equations are presented to calculate the change in the pH when the primary degradation product acts as a secondary buffer. This information can be used in the development of a parenteral product to predict, a priori, the concentration of buffer necessary for optimal pH maintenance. This knowledge can reduce the number of formulation screens required to determine the necessary buffer capacity for optimal drug stability.


Archive | 1990

Stable pharmaceutical composition of 3-(hydroxymethyl)-5,5-diphenylhydantoin disodium phosphate ester

Dale E. Herbranson; Earl R. Speicher; Leonard S. Rosenberg


Archive | 1989

Stable pharmaceutical composition

Leonard S. Rosenberg; Cheryl K. Black; Earl R. Speicher; Dietmar M. Wagenknecht


Archive | 1990

Stabile Arzneimittel mit 3-(hydroxymethyl)-5,5-diphenylhydantoin-dinatrium-phosphatester. The stable pharmaceutical with 3- (hydroxymethyl) -5,5-diphenylhydantoin disodium phosphate ester.

Dale E. Herbranson; Earl R. Speicher; Leonard S. Rosenberg


Archive | 1990

Composition pharmaceutique stable d'ester de phosphate de disodium de 3-(hydroxymethyl)-5,5-diphenylhydantoïne

Dale E. Herbranson; Leonard S. Rosenberg; Earl R. Speicher


Archive | 1990

Stable drugs with 3- (hydroxymethyl) -5,5-diphenylhydantoin disodium phosphatester.

Dale E. Herbranson; Earl R. Speicher; Leonard S. Rosenberg


Archive | 1989

Stable pharmaceutical composition containing esmolol

Earl R. Speicher; Cheryl K. Black; Dietmar M. Wagenknecht; Leonard S. Rosenberg


Archive | 1989

Stabile pharmazeutische zusammensetzung. The stable pharmaceutical composition.

Leonard S. Rosenberg; Cheryl K. Black; Earl R. Speicher; Dietmar M. Wagenknecht


Archive | 1989

Stabile pharmazeutische zusammensetzung

Leonard S. Rosenberg; Cheryl K. Black; Earl R. Speicher; Dietmar M. Wagenknecht

Collaboration


Dive into the Leonard S. Rosenberg's collaboration.

Researchain Logo
Decentralizing Knowledge